Veronesi, IT
Alessandro Veronesi, Limidi Di Soliera IT
Patent application number | Description | Published |
---|---|---|
20140199215 | UNIT FOR STERILIZING A WEB OF PACKAGING MATERIAL FOR A MACHINE FOR PACKAGING POURABLE FOOD PRODUCTS - There is described a unit for sterilizing a web of packaging material advanced along a given path, having, along a longitudinal portion thereof, a succession of pre-applied opening devices and adapted to be transformed in a plurality of sealed packages containing a pourable food product; the unit comprises a bath, containing a sterilizing agent in which the web with the opening devices is advanced, and an aseptic chamber connected to an outlet of the bath and housing drying mechanism for removing residual sterilizing agent from the web; the drying mechanism comprise an ejector located at a distance from the outlet of the bath and configured so as to direct a stream of air transversally to the web and onto the longitudinal portion of the web provided with the opening devices. | 07-17-2014 |
Alessandro Veronesi, Limid Di Soliera IT
Patent application number | Description | Published |
---|---|---|
20140196407 | PACKAGING MACHINE AND METHOD FOR PRODUCING SEALED PACKAGES OF A FOOD PRODUCT FROM A WEB OF A PACKAGING MATERIAL - There is described a packaging machine for producing sealed packages of pourable food products from a web of packaging material, comprising: an aseptic chamber through which web is fed and within which a sterilizing agent is applied onto web; a station which is arranged downstream from said aseptic chamber and in which a tube formed by web is, in use, fed; and a sealing device which separate chamber and station; packaging machine also comprise a conveyor fluidically connected with station and adapted to convey away residues of sterilizing agent from station. | 07-17-2014 |
Anna Maria Veronesi, Bastia Umbra IT
Patent application number | Description | Published |
---|---|---|
20120269771 | SIALOCHIMERIC COMPOUNDS - The present invention discloses a new class of compounds that exhibit an inhibitory effect on influenza virus type A and B, which may or may not be resistant to other drugs, as well as on other types of viruses, such as flavivirus but also on protozoa and other micro-organisms, their preparation methods, pharmaceutical formulations containing them and their use as medicinal products for the treatment of various conditions caused by particular microorganisms, including viruses, bacteria and protozoa, which affect animal and human health. | 10-25-2012 |
Daniele Veronesi, Aosta IT
Patent application number | Description | Published |
---|---|---|
20090135934 | METHOD FOR THE TRANSMISSION ON MULTIPLE-CARRIER COMMUNICATIONS SYSTEMS, AND CORRESPONDING TRANSMITTER AND COMPUTER-PROGRAM PRODUCT - A method for loading bits over a set of subcarriers of a multiple-carrier communications system comprises the operation of associating with the subcarriers respective numbers of bits chosen from among a plurality of available constellations. The method envisages definition of a performance target for the system and execution of bit loading, guaranteeing the aforesaid target on a plurality of subcarriers. The performance target can be a target error rate, such as a bit-error rate (BER), or else be transferred into a constraint, such as, for example, a threshold, in a metric of log-likelihood ratios (LLRs). In this case, there is preferably envisaged application to the signals received within the multiple-carrier system a function that estimates a signal to noise ratio on each sub-carrier. The aforesaid metric of log-likelihood ratios (LLRs) is hence defined as a function of said signal to noise ratios. | 05-28-2009 |
20110129040 | METHOD OF ESTIMATING LOG-LIKELIHOOD RATIOS AND RELATIVE S-FSK RECEIVER - A method of estimating log-likelihood ratios for first and second streams of samples of a received S-FSK signal demodulated using first and second carriers includes estimating channel and noise parameters associated with first and second transmitted values for the first and second streams of samples obtained from the received S-FSK modulated signal. Current signal-to-noise ratios are estimated for current samples of the first and second streams of samples obtained from the received S-FSK modulated signal using the channel and noise parameters. The estimated current signal-to-noise ratios are compared with values of a discrete ordered set and respective pairs of consecutive values of the discrete ordered set between which the estimated current signal-to-noise ratios are comprised are identified. Log-likelihood ratios are estimated for the current samples of the first and second streams. | 06-02-2011 |
Elena Veronesi, Finale Emilia (mo) IT
Patent application number | Description | Published |
---|---|---|
20130130381 | Method for obtaining a population of stromal progenitor cells - The present invention relates to a technique for obtaining stromal progenitor cells (SPC) from adipose tissue (AT) using incubation of very small volumes of AT with an enzyme solution, that can obtain SPC for autologous SPC-based medical applications to a greater number of individuals, possibly having a lower Body Mass Index (B.M.I), i.e. lower than | 05-23-2013 |
20140302605 | Method of obtaining a population of cells - A method of obtaining stromal progenitor cells (SPC) from subcutaneous adipose tissue by incubation of a very small volume of the subcutaneous adipose tissue in an enzyme solution produces SPC that are usable in medical applications based on autologous SPC even on individuals having a body mass index lower than 18.5. | 10-09-2014 |
Emanuela Veronesi, Spilimbergo IT
Patent application number | Description | Published |
---|---|---|
20130066433 | GLENOID SUPPORT FOR SHOULDER PROSTHESIS - Glenoid support for shoulder prostheses, able to be applied to the glenoid cavity ( | 03-14-2013 |
Marina Veronesi, Milan IT
Patent application number | Description | Published |
---|---|---|
20080233603 | Fluorine NMR spectroscopy for biochemical screening - High-Throughput Screening (HTS) of large compound libraries is the method of drug-lead discovery. It is now well accepted that for a functional assay, quality is more important than quantity. A biochemical NMR method originally proposed by Percival and Withers (Biochemistry, 1992, 31, 498-505) is extended to the screening of Ser/Thr kinases. The method requires the presence of a CF | 09-25-2008 |
Paolo Veronesi, Modena IT
Patent application number | Description | Published |
---|---|---|
20120282152 | Machine for Neutralizing the Bacterial Content of Hospital Waste or Other Special Waste, So as to be Able to Dispose of it as Waste Similar to Ordinary Solid Waste - The microwave sterilization chamber ( | 11-08-2012 |
Paolo Alberto Veronesi, Milan IT
Patent application number | Description | Published |
---|---|---|
20080286257 | Compounds for Use in Treating Abnormal Cell Proliferation, and Methods of Producing Same - The invention relates to the modification of recombinant human lysozyme from genetic engineering (rHLys) by reacting with activated polyethylene glycols (PEGs), which are partially binding or saturating with typical linkers one or more out of the six free amino groups of the five lysines (K) present in the rHLys chain. The resulting conjugate compounds of the invention (PEG-rHLys) and their addition salts, inhibit the abnormal cell proliferation and show remarkable antiproliferative and antimetastatic effects. The invention relates also to the use of the new compounds in the preparation of pharmaceutical compositions for treating a disease associated with abnormal cell proliferation, including cancer, by administering said conjugates to a subject in need thereof. | 11-20-2008 |
20090035260 | ENHANCED NASAL COMPOSITION OF ACTIVE PEPTIDE - A pharmaceutical composition has a therapeutically effective amount of at least one of: a pharmaceutically active nasal peptide, its pharmaceutically acceptable salt and its peptidic fragment. The composition also contains an absorbefacient effective amount of THAM in a pharmaceutically acceptable, aqueous liquid diluent or carrier. The composition is provided in a convenient form for nasal administration. In one embodiment, the peptidic fragment may be selected physiologically active lymphokines and monokines, peptidic enzymes, proteic vaccines, peptidic toxoids and personalized proteins derived from genoma. In another embodiment, the peptidic fragment may be selected from the peptide hormones and hormone antagonists buserelin, desmopressin, vasopressin, angiotensin, felypressin, octreotide, somatropin, thyrotropin (TSH), somatostatin, gosereline, thryptorelin and insulin selected from the group consisting of cow and pig, synthetic and recombinant. | 02-05-2009 |
20100029579 | ANTIVIRAL COMPOUNDS - The invention provides a new class of compounds exhibiting an inhibitory effect on neuraminidase (NA), hemagglutinin (HA) and structural M | 02-04-2010 |
20120269771 | SIALOCHIMERIC COMPOUNDS - The present invention discloses a new class of compounds that exhibit an inhibitory effect on influenza virus type A and B, which may or may not be resistant to other drugs, as well as on other types of viruses, such as flavivirus but also on protozoa and other micro-organisms, their preparation methods, pharmaceutical formulations containing them and their use as medicinal products for the treatment of various conditions caused by particular microorganisms, including viruses, bacteria and protozoa, which affect animal and human health. | 10-25-2012 |
Sergio Veronesi, Basilicanova (parma) IT
Patent application number | Description | Published |
---|---|---|
20080202352 | Microwave Oven and Apparatus for Preparing Ready-to-Eat Hot Meals Including Said Microwave Oven - The present invention regards a microwave oven ( | 08-28-2008 |
20110020506 | Packaged Frozen Ready-Made Meal - Packaged frozen ready-made meal including a flared receptacle made of a rigid material permeable to microwaves, containing a first frozen food component at the bottom, a second frozen food component having a substantially plate-like shape, having a substantially fluid consistency at a temperature above 0° C., and a closure element, wherein the second frozen food component having a substantially plate-like shape is engaged in the manner of a plug with the internal wall of the receptacle, spaced apart from the first frozen food component. | 01-27-2011 |
Stefano Veronesi, Pisa IT
Patent application number | Description | Published |
---|---|---|
20120260846 | METHOD FOR FORMING BULK CRYSTALS, IN PARTICULAR MONOCRYSTALS OF FLUORIDES DOPED WITH RARE-EARTH IONS - A method for forming a bulk crystal from precursors in the molten state, of solidification and growth around a seed of a material having a defined crystalline structure, includes subjecting the crystalline solid phase obtained at the end of the growth to a first controlled cooling step performed at a first higher cooling rate until a predetermined threshold temperature is reached, and to a subsequent controlled cooling step from the threshold temperature, performed at a second cooling rate lower than the first cooling rate. | 10-18-2012 |
Stefano Veronesi, S. Giacomo R. Mirandola (modena) IT
Patent application number | Description | Published |
---|---|---|
20080230475 | Filter for the Removal of Substances from Blood Products - A filter device for the depletion of the leukocyte content from blood products comprising: a porous element comprising at least one fibrous web having a pore size suitable for leukocyte removal (possibly the range for the pore size should be defined), said web comprising fibres of a hydrophobic polymer coated with a hydrophilic polymer suitable to enhance the CWST of said hydrophobic polymer, characterised in that said web further includes adsorbent particles having a mean diameter lower than 30 μm, said particles being bonded to said fibres by means of said hydrophilic polymer coating said fibres. | 09-25-2008 |
Susanna Lucia Veronesi, Milan IT
Patent application number | Description | Published |
---|---|---|
20100029579 | ANTIVIRAL COMPOUNDS - The invention provides a new class of compounds exhibiting an inhibitory effect on neuraminidase (NA), hemagglutinin (HA) and structural M | 02-04-2010 |